This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Momotaro-Gene Inc., Okayama University. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 10 
1 out of 138 
Years Active: 2015
Title: Namho Huh: Innovator in Adenovirus Vector Technology.
Introduction
Namho Huh is a prominent inventor based in Okayama, Japan. He is known for his significant contributions to the field of biotechnology, particularly in the development of adenovirus vectors. His work has implications for gene therapy and cancer treatment.
Latest Patents
Namho Huh holds a patent for a REIC-expressing adenovirus vector. The objective of this invention is to provide an adenovirus vector that expresses the REIC/Dkk-3 protein at a high level. This vector contains a DNA construct for the expression of REIC/Dkk-3 DNA, which is prepared by ligating from the 5' terminal side.
Career Highlights
Throughout his career, Namho Huh has worked with notable institutions, including Okayama University and Momotaro Gene Inc. His research has focused on advancing the understanding and application of adenoviral vectors in therapeutic settings.
Collaborations
Namho Huh has collaborated with esteemed colleagues such as Hiromi Kumon and Masakiyo Sakaguchi. These collaborations have contributed to the advancement of his research and the development of innovative solutions in biotechnology.
Conclusion
Namho Huh's work in adenovirus vector technology exemplifies the innovative spirit of modern biotechnology. His contributions continue to pave the way for advancements in gene therapy and cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile